- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
33 Cards in this Set
- Front
- Back
|
Why are cancers not considered a "single" disease?
|
There is extreme variability with respect to:
- Cell type - Molecular alterations - State of differentiation |
|
What components of an animal immune to a tumor provides protection when injected into a naive animal which is then subjected to that same tumor?
|
Cell mediated immune response:
- T cells - CD8 cells - CD4 cells (depends on tumor) |
|
What causes the immune system to recognize a tumor when the tumor originated from self-cells?
|
Tumor cells express immunogenic antigens
|
|
What are some mechanisms by which immunogenic antigens develop on tumor cells?
|
Oncogenic virus → viral protein
Mutagen → mutant protein Chromosomal rearrangement → fusion protein Mutation → de novo expression |
|
What are two reasons why the immune system might recognize self-antigens?
|
Intolerance to self-antigen
Low affinity (weak) responses always present |
|
How do T cells detect tumor antigens?
|
Dendritic cells present antigen via MHC I / II pathways and then go to lymph nodes for recognition by T cells
|
|
How do effector CD8 T cells seek out and destroy the tumor?
|
The tumor antigens are broken down via proteosomes and presented via MHC I
Primed CD8 T cells find these MHC I complexes with tumor antigen and destroy the tumor |
|
Why are CD4 T cells less involved in the immune response against a tumor than CD8 T cells?
|
Many tumors are MHC II negative, thus do not get recognized by effector CD4 T cells
|
|
How do effector CD4 T cells seek out and help the destruction of tumor cells?
|
Two ways:
1. If the tumor expresses MHC II, CD4 T cells can directly seek these tumor cells and help destroy them 2. APCs around the tumor present tumor antigen on MHC II, which are recognized by CD4 T cells, leading to inflammation and tumor destruction |
|
What are the mechanisms by which the immune system kills tumor cells?
|
CD8 T cells (cytotoxic T cells) recognize MHC I on tumor and kills cells
Tumor antigen attracts macrophages which: - Attract CD4 T cells via MHC II - Release cytokines and reactive oxygen species |
|
What do CD4 T cells do once they are recruited to a tumor?
|
Secrete TNF which leads to inflammation
|
|
How can a tumor escape immunosurveillance?
|
Lose MHC I
Tolerance Immunosuppression Lack or loss of antigen |
|
How are tumor cells that have lost MHC I proteins still killed by the immune system?
|
NK cells
|
|
How do NK cells avoid killing host cells?
|
NK cells recognize MHC I on host cells via NK inhibitory receptor and are turned off
|
|
How do NK cells kill tumor cells that have lost MHC I proteins?
|
NK cell inhibitory receptors on NK cells do not see MHC I on tumor and are turned on
(Also need a second "on" signal) |
|
What are ways that a tumor can evade host responses?
|
The tumor is not sufficiently immunogenic, lacking recognizable antigen
The tumor impairs the host response - Tolerance - Tumor is immunosuppressive Failed presentation of antigen - Loss of MHC I - Loss of tumor antigen expression Tumor overwhelms immune system |
|
Why is immunotherapy an attractive choice for cancer treatment over surgery, chemotherapy, or radiation?
|
High specificity
Precise locating of tumor cells Memory |
|
What are the four immunotherapeutic strategies against cancer?
|
Non-specific immune stimulation
- Jazzes up immune system Antibody immunotherapy Increase pre-existing immune responses - Amplify original anti-tumor immune response Stimulate new immune response (and/or existing response) |
|
How is the method of non-specific immune stimulation accomplished?
|
Infect patients to boost immune response
|
|
What was the general mechanism of non-specific immune stimulation?
|
1. Infect patient with bacteria
2. Bacteria cause macrophages to secrete TNF 3. TNF leads to vessel thrombosis, cutting off blood supply to tumor |
|
What was the problem with non-specific immune stimulation and what is the one case in which it seemed to benefit patients?
|
TNF is too toxic
Response against BCG (mycobacterium) infection has some localized effect in bladder cancer |
|
What are the ways by which antibodies used in antibody immunotherapy can kill tumor cells?
|
Antibody-induced complement activation:
- Lysis - NK cells and macrophage recruitment for antibody-dependent cellular cytotoxicity (ADCC) Anti-proliferative antibodies Pro-apoptotic antibodies Toxin-conjugated antibody Radioactive-antibody |
|
What is an example of an anti-proliferative antibody used for immunotherapy?
|
Her2neu for breast cancer
|
|
What is an example of a pro-apoptotic antibody used for immunotherapy?
|
CD20 against lymphoma
|
|
What are ways by which pre-existing immune responses to the tumor are amplified?
|
IL-2 therapy
Adoptive cellular therapy Inhibit inhibitory T cell actions |
|
What is the general mechanism of IL-2 therapy?
|
Cause proliferation in T cells
|
|
What are cons of IL-2 therapy?
|
Toxicity
Limited efficacy |
|
What is the general mechanism of adoptive cellular therapy?
|
1. Expand patient's anti-tumor T cells ex-vivo
2. Re-infuse patient with expanded T cells (or lymphocyte activated killer cells from monocytes activated by IL-2) |
|
What is an example of inhibiting the inhibitory T cell responses?
|
Antibody blocking CTLA4 (inhibitory receptor on T cells and on inhibitory T cells)
|
|
What is a con of inhibiting the inhibitory receptors of T cells?
|
Can lead to autoimmunity
|
|
How are new immune responses stimulated?
|
Prophylactic vaccines
Cancer antigen-dendritic vaccine |
|
What is an example of a prophylactic vaccine against cancer?
|
HPV vaccine
|
|
What is the mechanism of using a cancer antigen-dendritic cell vaccine?
|
1. Grow dendritic cells with specific antigen and cytokine
2. Re-infuse patient with cells |